A Crossover Study in the Treatment of Patients With COPD

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

September 30, 2007

Study Completion Date

October 31, 2007

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Formoterol Fumurate inhalation solution 20 mcg

DRUG

Ipratropium bromide 18 mcg and albuterol sulfate 103 mcg

Trial Locations (15)

26505

Research Site, Morgantown

28207

Research Site, Charlotte

29303

Research Site, Spartanburg

29340

Research Site, Gaffney

32405

Research Site, Panama City

32504

Research Site, Pensacola

37601

Research Site, Johnson City

70584

Research Site, Sunset

78205

Research Site, San Antonio

80033

Research Site, Wheat Ridge

80206

Research Site, Denver

83814

Research Site, Coeur d'Alene

92120

Research Site, San Diego

97213

Research Site, Portland

99204

Research Site, Spokane

All Listed Sponsors
lead

Dey

INDUSTRY

NCT00462540 - A Crossover Study in the Treatment of Patients With COPD | Biotech Hunter | Biotech Hunter